Atlas Trials

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).

Clinical trial NCT05228730 · TERMINATED

Trial details

NCT number
NCT05228730
Sponsor
Murdoch Childrens Research Institute
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2022-05-02
Primary completion
2022-07-25
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.